COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

Monthly Archives:
November 2013

21

November
2013

category:

503b Compounding

Today’s Shortages

ASHP/FDA Atropine Sulfate Injection Dextrose (50%) Injection Lidocaine Injection Ondansetron Injection Sincalide Injection

read more

20

November
2013

category:

503b Compounding

Canada: NDP calls for mandatory disclosure of drug shortages

Drug shortages have become a major problem in Canada – and costly headache for provinces – but an NDP MP is proposing a bill that will address this problem. “This legislation can provide health professionals with the crucial notification they need to plan treatment for their patients during drug shortages,” said NDP MP Djaouida Sellah (Saint-Bruno—Saint-Hubert).  […]

read more

20

November
2013

category:

503b Compounding

Drug compounding firm PharMEDium in $1 bln sale talks -sources

Nov 19 (Reuters) – PharMEDium Services LLC, a venture capital-backed provider of pharmacy compounding services to hospitals, is in discussions to sell itself for close to $1 billion, according to people familiar with the matter. The Lake Forest, Illinois-based company is working with JPMorgan Chase & Co and is in talks with a small group […]

read more